10-Q: Vynleads, Inc. Q1 2026 Financials Show Increased Net Loss

Vynleads, Inc. reported a net loss of $96,956 for Q1 2026, an increase from $80,970 in Q1 2025, driven by higher operating expenses.

Summary

• Vynleads, Inc. reported zero revenue for the first quarter of 2026 and 2025.
• The company incurred a net loss of $96,956 for the three months ended March 31, 2026, compared to a net loss of $80,970 for the same period in 2025.
• Total costs and operating expenses increased by 19% to $113,210 in Q1 2026 from $98,271 in Q1 2025, primarily due to the use of a third-party software development team.
• Selling, general, and administrative expenses rose by 23% to $92,942 in Q1 2026 from $75,313 in Q1 2025.
• The company's cash balance significantly decreased from $44,628 at December 31, 2025, to $262 at March 31, 2026.
• The working capital deficit widened to $416,887 at March 31, 2026, from $352,431 at December 31, 2025.
• Management has identified substantial doubt about the company's ability to continue as a going concern due to recurring operating losses and negative cash flows.
• The company estimates it requires approximately $5,500,000 in additional working capital over the next 12 months.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this filing as negative due to the increased net loss, zero revenue, deteriorating liquidity, and the explicit statement of substantial doubt regarding the company's ability to continue as a going concern.

Positives

• The company continues to operate on a going concern basis, with financial statements prepared accordingly.
• Mr. Mannine, the CEO, voluntarily waived all cash compensation and related accruals since September 21, 2020, contributing services in-kind valued at $32,500 in Q1 2026 and Q1 2025.

Negatives

• Zero revenue reported for both Q1 2026 and Q1 2025.
• Net loss increased by approximately 19.8% to $96,956 in Q1 2026 from $80,970 in Q1 2025.
• Operating expenses increased by 19% due to the use of a third-party software development team.
• Selling, general, and administrative expenses increased by 23%.
• Cash balance decreased drastically from $44,628 to $262.
• Working capital deficit increased to $416,887.
• Substantial doubt exists regarding the company's ability to continue as a going concern.
• The company requires an estimated $5.5 million in additional working capital over the next 12 months.
• There are no firm commitments for additional capital.
• One note payable, originally $50,000, is currently in default.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring operating losses and negative cash flows.
• The company requires significant additional capital ($5.5 million estimated) to fund operations and growth plans, with no assurance of securing it.
• Failure to raise sufficient capital could force the company to curtail or discontinue operations, potentially leading to bankruptcy.
• The company relies on a single supplier for its herbal/natural supplements inventory, posing a risk of supply interruption and material business impact.
• The company has a material weakness in internal control over financial reporting due to a lack of segregation of duties, which could lead to misstatements in financial statements.
• A consultant has filed unauthorized UCC liens against the company and its officers, alleging non-payment of royalty amounts, though the company disputes these claims.
• Several notes payable are due within one year of execution or upon securing $1 million in total investment capital, with one note currently in default.

Future Outlook

The company requires substantial funds to expand service and product offerings, market services, and grow its infrastructure. Management estimates approximately $5,500,000 in additional working capital is needed over the next 12 months for product development, marketing, infrastructure, and operating expenses. There are no firm commitments for this additional capital, and failure to secure it could adversely impact revenue and operations, and potentially force curtailment or discontinuation of operations.

Management Comments

• Management believes that there is substantial doubt about our ability to continue as a going concern.
• Our ability to meet our current and projected obligations depends on our ability to generate sufficient sales and to control expenses and will require that we seek additional capital through private and/or public financing sources.
• There can be no assurances that we will achieve our forecasted financial results or that we will be able to raise additional capital to operate our business.
• Any such failure would have a material adverse impact on our liquidity and financial condition and could force us to curtail or discontinue operations entirely and could require us to file for protection under bankruptcy laws.
• Management identified a material weakness in internal control over financial reporting due to a lack of segregation of duties, which is expected to be mitigated upon subsequent funding with the hiring of additional personnel.

Industry Context

StockSavvy.ai notes that Vynleads operates in the wellness technology sector, specifically focusing on metabolic health and chronic conditions like type 2 diabetes. The company's app-based program, 'Done With Diabetes,' utilizes AI coaching and a lifestyle blueprint. This aligns with broader industry trends towards digital health solutions, personalized wellness, and the integration of AI in healthcare. However, the company's current financial performance, characterized by zero revenue and significant losses, indicates a challenging path to market penetration and profitability within this growing but competitive space.

Corporate Governance

Legal Proceedings

• The company is disputing claims from a consultant regarding royalty payments and is pursuing the removal of unauthorized UCC liens filed against the company and its officers.
• One note payable, originally $50,000, executed on November 18, 2019, is currently in default.

Related Party Transactions

• Mr. Mannine, the CEO, voluntarily waived all cash compensation and related accruals since September 21, 2020. His services are recorded as an in-kind contribution valued at $32,500 for the three months ended March 31, 2026 and 2025.
• Several notes payable were executed with individuals, with terms including due dates tied to securing $1 million in total investment capital.

Stakeholder Impact

• Shareholders: The company's going concern issues, increasing net loss, and need for significant capital raise pose a high risk of investment loss.
• Creditors: The default on one note payable and the overall financial precariousness increase the risk for creditors.
• Employees: Uncertainty about the company's ability to continue operations could impact employee job security.
• Suppliers: Reliance on a single supplier for inventory creates a risk of supply disruption, potentially impacting the company's ability to fulfill orders.

Next Steps

• Secure approximately $5.5 million in additional working capital over the next 12 months.
• Continue development of new indicators for the Lifestyle Blueprint platform.
• Add print versions of the DWD Protocol.
• Expand the supplement product line.
• Offer additional subscription content.
• Fund increases in advertising and marketing costs.
• Develop additional infrastructure to support expected growth.
• Pursue action to remove remaining unauthorized UCC liens.
• Complete the application for forgiveness of the PPP Loan.

Key Dates

Recommendation

The company exhibits severe financial distress with zero revenue, increasing net losses, a significant working capital deficit, and explicit statements of substantial doubt regarding its ability to continue as a going concern. The need for a substantial capital raise with no firm commitments, coupled with a default on a note payable and identified material weaknesses in internal controls, presents an unacceptably high risk profile for investors.

Keywords

Vynleads, 10-Q, Quarterly Report, Financial Statements, Metabolic Health, Diabetes, Wellness Technology, Net Loss, Going Concern, Working Capital, SEC Filing